Best eQMS for FDA QMSR 2026 Buyer’s Guide

Best eQMS for FDA QMSR — the 2026 Transition Guide

Last reviewed: Jul 18, 2026 · Next review: Oct 31, 2026

Six leading platforms evaluated for the FDA Quality Management System Regulation — effective 2026-02-02, amending 21 CFR Part 820 (formerly the Quality System Regulation) — ranked by ISO 13485 alignment, DHF support, UDI, complaint handling, and validation pack depth.

The FDA QMSR final rule (89 FR 7496, published 2024-01-31) amended 21 CFR Part 820 (formerly the Quality System Regulation) effective 2026-02-02. It incorporates ISO 13485:2016 by reference and overlays FDA-specific provisions for UDI, complaint handling, and Medical Device Reporting. For most manufacturers already certified to ISO 13485, the transition is incremental rather than re-platforming. This guide evaluates Complere alongside Greenlight Guru, MasterControl, Veeva Vault QMS, Qualio, and ETQ Reliance / Octave on QMSR-specific criteria. Ranked from #1 (recommended fit) to #6.

  • FDA QMSR aligned
  • ISO 13485 / ISO 14971
  • FDA 21 CFR Part 11
  • EU GMP Annex 11
  • ALCOA+
QMSR in plain language

Three things changed when the QMSR amended Part 820 on 2026-02-02. (1) ISO 13485 by reference. The bulk of QMSR content is ISO 13485:2016 — Document Control, Records, Management Responsibility, Resource Management, Product Realisation (Design Controls + DHF), Measurement / Analysis / Improvement (Internal Audits, CAPA, Nonconformance). (2) FDA-specific overlays. UDI (21 CFR Part 830), Medical Device Reporting (21 CFR Part 803), Complaint Handling, Labelling. (3) Definitions update. Some terminology aligned with ISO 13485. The QMSR did not introduce new technical requirements that demand re-validation of existing systems.

What QMSR readiness looks like

(1) Written QMSR alignment statement from your eQMS vendor. (2) Validation pack regenerated with QMSR sub-clause traceability (URS / RA / TM updated; IQ / OQ / PQ scripts re-aliased). (3) SOPs updated to reference QMSR (not Part 820). (4) Training records showing staff trained on QMSR transition. (5) FDA-specific overlay evidence: UDI tracking on device records, MDR workflow with §803 timelines, complaint handling per §820.35(a) / ISO 13485 §8.2.2. (6) Design and development records retained per ISO 13485 §4.2.5 (device lifetime, not less than two years from release).

Built for FDA QMSR

QMSR-aligned controls Complere ships in every medical device tenant.

QMSREffective 2026-02-02 (amended Part 820)
ISO 13485+ ISO 14971 + Part 11 aligned
CSV + CSAValidation pack per module
Per-customerDatabase, in a customer-selected region

The 6 best eQMS platforms for FDA QMSR

Ranked by QMSR readiness for medical device manufacturers. Click each card for the full like-for-like comparison.

#1 — Recommended fit

Complere eQMS

QMSR strengths. ISO 13485:2016 + ISO 14971 + FDA 21 CFR Part 11 alignment built in. Full CSV protocol pack (VMP, URS, RA, TM, IQP, OQP, PQT, Part 11 checklist, ATS) per module on day one. Events module records complaints with audit trail and CAPA linkage. Documents module supports controlled SOPs with audit trail and e-signatures. DHF traceability operated through linked items across Documents + Risk + Change. Hosting in a region the customer selects (Professional and Enterprise plans) for OUS commercialisation.

Best for. Medical device manufacturers needing QMSR alignment alongside multi-vertical scope (combination products, in-licensed pharma) with full CSV pack delivered and regional residency.

#2

Greenlight Guru

QMSR strengths. Medical-device-exclusive QMS + Product Development + Clinical Evidence platforms. First-class Design Controls and DHF modules. ISO 13485, ISO 14971, ISO 14155:2020, FDA 21 CFR Part 820 / Part 11, FDA 510(k), QMSR, EU MDR. [source: greenlight.guru, accessed 2026-07-18]

Best for. Medical-device-only manufacturers with deep Design Controls and clinical evidence needs.

#3

MasterControl

QMSR strengths. Quality Excellence Suite covers Documents, CAPA, Audit, Risk, Training, Change, Quality Event, Deviations, Nonconformance. Manufacturing Excellence (eDHR, EBR) supports DHR / device manufacturing records. ISO 13485 + Part 820 + QMSR alignment referenced. [source: mastercontrol.com, accessed 2026-07-18]

Best for. Enterprise medical device manufacturers needing eDHR / DHR alongside QMS, plus US federal / FedRAMP scope.

#4

Veeva Vault QMS

QMSR strengths. Veeva Quality Cloud (QMS, QualityDocs, Training, Validation Mgmt, LIMS) on the Vault platform. Vault AI custom agents (complaint intake, LIMS). Industries include MedTech alongside biopharma. [source: veeva.com, accessed 2026-10-28]

Best for. Larger medical device manufacturers already on Vault, especially those with combination-product complexity.

#5

Qualio

QMSR strengths. AI-assisted compliance with Foundation / Growth / Scale tiers. Documents, Design Controls, Risk, Training, Change, Audits, CAPAs, Suppliers. Industries: medical devices, pharma, biotech, SaMD. [source: qualio.com, accessed 2026-07-18]

Best for. SMB / mid-market medical device companies wanting tier-based pricing with explicit Design Controls.

#6

ETQ Reliance / Octave Reliance

QMSR strengths. Multi-industry quality + EHS with 40+ apps. Document Control, CAPA, Audit, Training, Supplier Quality, Change, Non-conformance. Standards: ISO 9001, FDA 21 CFR Part 11, EU Annex 11. [source: octave.com, accessed 2026-07-18]

Best for. Multi-industry medical device manufacturers (automotive, aerospace + MedTech) needing one configurable platform.

QMSR-specific comparison matrix

Sourced from each vendor’s public materials with citations and access dates. QMSR-specific row for each FDA-overlay (UDI, MDR, complaint handling, DHF).

QMSR criteria Complere Greenlight MasterControl Veeva Qualio Octave
QMSR alignment statementISO 13485:2016 clause mapping documented; QMSR incorporates ISO 13485Yes (QMSR named)[1]Yes[2]Verify with vendorYes (Part 820 / QMSR)[4]Verify with vendor
ISO 13485:2016 alignmentYesYes[1]Yes[2]Yes[3]Yes[4]Not described on cited page[5]
Design Controls / DHFLimited — via linked itemsFirst-class platform[1]Module + eDHR[2]Not described on cited page[3]Module[4]Limited[5]
UDI tracking on device recordsNo dedicated UDI featureNot described on cited page[1]Yes[2]Verify with vendorYes[4]Verify with vendor
Complaint handling + MDR (§803) workflowEvents module records complaints; linked CAPAFirst-class[1]Quality Event module[2]Complaints[3]CAPAs / Complaints[4]CAPA module[5]
Full CSV pack with QMSR traceabilityVMP, URS, RA, TM, IQP, OQP, PQT, Part 11 checklist, ATSIQ protocol + Validation Test Report (CSA / ISO/TR 80002-2)[6]Validation plan, IQ protocols, TOQ, TPQ and report included with vendor validation services[9]Validation package for each release (IQ/OQ, traceability, summary report); Validation Management is a separate execution product[8]Validation pack + automated document packs[7]Validation services[5]
FDA 21 CFR Part 11 alignmentAligned + Part 11 checklist + ATSYes[1]Yes[2]Yes[3]Yes[4]Yes[5]
Record retention (ISO 13485 §4.2.5 via §820.35)No retention-schedule configurationFirst-class[1]Yes[2]Vault retention[3]Yes[4]Yes[5]
EU MDR alongside QMSRAlignedEU MDR named[1]Yes[2]Yes (Vault)[3]Yes[4]Yes[5]
Regional data residencyCustomer-selected region — EU, India, GCC, ANZ or US (Professional and Enterprise plans)Not detailed publiclyFedRAMP for US gov[2]Not described on pages reviewed [accessed 2026-10-28]Not detailed publiclyNot detailed publicly
Sources (accessed 2026-07-18): [1] greenlight.guru · [2] mastercontrol.com · [3] veeva.com · [4] qualio.com · [5] octave.com · [6] greenlight.guru/software-validation-guidance (accessed 2026-10-28) · [7] qualio.com/validation (accessed 2026-10-28) · [8] veeva.com/resources/veeva-vault-validation-product-brief (accessed 2026-10-28) · [9] mastercontrol.com/library/quality/pharma-software-validation (accessed 2026-10-28). All vendor names are trademarks of their respective owners. Complere is independent and not affiliated with, endorsed by, or sponsored by any vendor listed.

Which eQMS fits your QMSR programme

Pick by primary constraint.

If multi-vertical + full CSV pack are constraints

Choose Complere

You manufacture medical devices alongside combination products, in-licensed pharma assets, or biologics-derived therapies and want one tenant. You need a full CSV protocol pack delivered per module on day one. You need hosting in a region the customer selects — EU, India, GCC, ANZ or US — fixed in the master agreement (Professional and Enterprise plans). Design Controls / DHF traceability operated through linked items rather than first-class module.

If MedTech-only depth or eDHR is constraint

Choose Greenlight, MasterControl, Veeva, Qualio, or Octave

Choose Greenlight Guru if MedTech-only and Design Controls / DHF / Clinical Evidence are first-class. Choose MasterControl for enterprise eDHR / DHR alongside QMS + FedRAMP. Choose Veeva Vault QMS if already on Vault platform with combination-product complexity. Choose Qualio for SMB MedTech with explicit Design Controls and AI features. Choose Octave Reliance for multi-industry MedTech alongside automotive / aerospace / EHS.

Frequently asked questions

What is the FDA QMSR?

The FDA Quality Management System Regulation (QMSR) is the final rule that amended 21 CFR Part 820 (formerly the Quality System Regulation) effective 2026-02-02. It harmonises FDA’s quality system requirements for medical device manufacturers with ISO 13485:2016, while retaining FDA-specific provisions on labelling, UDI, complaint handling, and Medical Device Reporting (MDR). The QMSR applies to all medical devices marketed in the US.

How does the QMSR differ from 21 CFR Part 820?

Part 820 was a US-specific regulation built independently from ISO 13485, leading to duplicate quality systems for manufacturers selling globally. The QMSR incorporates ISO 13485:2016 by reference and overlays FDA-specific provisions where ISO 13485 is silent (e.g. UDI under §830, complaint handling, MDR reporting under §803). For most manufacturers already certified to ISO 13485, the QMSR transition is incremental — verify FDA-specific overlays are documented in your QMS.

Do I need a new eQMS for QMSR compliance?

No. eQMS platforms aligned to ISO 13485 + Part 820 generally remain valid under QMSR. The transition is procedural rather than technological: update SOPs to reference QMSR (instead of Part 820), re-train staff, and ensure FDA-specific overlays (UDI, MDR reporting, complaint handling) are evidenced. Verify your vendor’s QMSR alignment statement and confirm the validation pack references the QMSR sub-clauses where Part 820 was previously cited.

What does the QMSR require for Design Controls and DHF?

The QMSR requires design and development controls for Class II and Class III devices, plus the Class I devices listed in §820.10(c), by incorporating ISO 13485 §7.3 (Design and Development). The QMSR no longer uses the term Design History File; the §7.3 records — design inputs, outputs, reviews, V&V, transfer, changes — serve the same purpose and are retained per ISO 13485 §4.2.5 via §820.35: at least the lifetime of the device as defined by the manufacturer, but not less than two years from release. eQMS platforms support these records either as a first-class Design Controls module or through linked records across Documents, Risk, Change, and CAPA.

Does QMSR change UDI or Medical Device Reporting (MDR) requirements?

No fundamental change. UDI requirements under 21 CFR Part 830 remain in force unchanged. MDR (adverse event reporting) under 21 CFR Part 803 remains unchanged. The QMSR clarifies how these FDA-specific obligations sit alongside ISO 13485-aligned QMS processes. The eQMS must support UDI tracking on device records, MDR workflow with FDA reporting timelines (5 / 30 day windows), and traceable linkages between complaints, MDR reports, and CAPA.

When did the FDA QMSR become effective?

The FDA QMSR final rule was published 2024-01-31 (89 FR 7496) with a 2-year transition period. The QMSR became effective 2026-02-02. As of that date, Quality System Regulation references in regulatory submissions and inspection findings transition to the QMSR. Quality system documentation should be updated to cite the QMSR going forward; legacy records citing the former Part 820 text remain valid for their original retention period.

How does an eQMS support QMSR complaint handling?

QMSR (via ISO 13485 §8.2.2 + FDA overlays) requires a documented complaint handling procedure: complaint receipt, evaluation for MDR reportability, investigation, root cause analysis, CAPA linkage, response to complainant, and trending. The eQMS Events / Complaints module must support each step with audit trail, evaluator roles, MDR reportability decision logging, time-bound investigation workflow, CAPA linkage, and trending dashboards. Complere records complaints in the Events module, with audit trail and a linked CAPA workflow; the complaint-handling procedure itself is held as a controlled document in the Documents module.

How does QMSR interact with EU MDR and other international regulations?

QMSR’s harmonisation with ISO 13485 reduces the gap with EU MDR (which also references ISO 13485 for QMS) and other ISO 13485-aligned regulations (Health Canada CMDR, Japan MHLW, ANVISA Brazil, TGA Australia). A single ISO 13485-aligned QMS now serves more jurisdictions with FDA-specific overlays as needed. Multi-vertical eQMS platforms with regional residency (Complere) are well-positioned for global manufacturers managing both QMSR and EU MDR simultaneously.

What’s the impact of QMSR on legacy validation evidence?

Validation evidence (URS, IQ, OQ, PQ, Part 11 checklist, ATS) generated under Part 820 remains valid as historical records. Going forward, new validation activities should reference the QMSR sub-clauses (which alias to Part 820 + ISO 13485). Most eQMS validation packs alias their requirement traceability to both Part 820 and ISO 13485 — re-aliasing to QMSR is a documentation update, not a re-validation. Verify your vendor regenerates the validation pack under QMSR going forward.

How do I evaluate eQMS vendors for QMSR readiness?

Ask each vendor for: (1) a written QMSR alignment statement covering ISO 13485:2016 + FDA-specific overlays (UDI, MDR, complaint handling); (2) the validation pack with QMSR sub-clause traceability; (3) Design Controls / DHF support model (first-class module vs linked records); (4) record retention meeting ISO 13485 §4.2.5 as the QMSR applies it (at least the device lifetime, not less than two years from release); (5) a roadmap for QMSR-driven feature updates. Compare against the same 14-criteria scoring matrix used for general eQMS evaluation, with QMSR-specific overlays as additional rows.

Ready to see how Complere supports your QMSR programme?

Book a QMSR walkthrough. We’ll review your scope, regulatory submissions, and validation pack against QMSR sub-clauses.

Disclaimer. Information about Greenlight Guru, MasterControl, Veeva, Qualio, and ETQ Reliance / Octave sourced from public materials accessed 2026-07-18. All vendor names are trademarks of their respective owners. Complere is independent and not affiliated with, endorsed by, or sponsored by any vendor listed in this guide. This guide reflects Complere’s interpretation of public information and the FDA QMSR final rule (89 FR 7496); verify all details with each vendor and with current FDA guidance. Last reviewed: 2026-07-18. Next review: 2026-10-31. Corrections: legal@complere.tech.